BioNTech SE
BNTX
$93.66
$0.320.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -71.92% | -958.16% | 92.35% | -0.27% | -258.18% |
| Total Depreciation and Amortization | 465.69% | -126.22% | 150.86% | 28.51% | 76.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -108.63% | 2,013.70% | 177.31% | -405.20% | 135.14% |
| Change in Net Operating Assets | 128.70% | -135.16% | 23.54% | 235.60% | 39.10% |
| Cash from Operations | -234.10% | -60.53% | 448.95% | 120.24% | -66.36% |
| Capital Expenditure | 11.40% | -75.29% | -36.46% | 40.23% | 27.51% |
| Sale of Property, Plant, and Equipment | 162.86% | -79.40% | 497.43% | 7.85% | -29.48% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 191.11% | -226.71% | -2,331.68% | -102.97% | 101.63% |
| Cash from Investing | 195.87% | -193.30% | -1,380.08% | -105.57% | 102.88% |
| Total Debt Issued | 473.13% | -- | -- | -- | -- |
| Total Debt Repaid | 36.84% | -65.22% | 13.53% | 3.62% | -89.04% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 282.00% | -23.81% | 10.93% | -3.94% | -86.62% |
| Foreign Exchange rate Adjustments | -339.42% | 106.48% | -340.74% | 161.63% | -216.87% |
| Miscellaneous Cash Flow Adjustments | -2.28% | 1,045.08% | -84.39% | 153.92% | -5.09% |
| Net Change in Cash | 192.32% | -1,263.04% | -315.03% | -78.43% | 204.15% |